These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19604530)

  • 1. [Locomotion disturbances in Huntington's disease].
    Delval A; Krystkowiak P
    Rev Neurol (Paris); 2010 Feb; 166(2):213-20. PubMed ID: 19604530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of locomotion disorders in Huntington's disease].
    Delval A; Krystkowiak P; Blatt JL; Delliaux M; Destée A; Derambure P; Defebvre L
    Neurophysiol Clin; 2008 Apr; 38(2):117-25. PubMed ID: 18423332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of external cueing on gait in Huntington's disease.
    Delval A; Krystkowiak P; Delliaux M; Blatt JL; Derambure P; Destée A; Defebvre L
    Mov Disord; 2008 Jul; 23(10):1446-52. PubMed ID: 18512747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a disorder of locomotor timing in Huntington's disease.
    Bilney B; Morris ME; Churchyard A; Chiu E; Georgiou-Karistianis N
    Mov Disord; 2005 Jan; 20(1):51-7. PubMed ID: 15390128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of attentional resources on gait performance in Huntington's disease.
    Delval A; Krystkowiak P; Delliaux M; Dujardin K; Blatt JL; Destée A; Derambure P; Defebvre L
    Mov Disord; 2008 Apr; 23(5):684-9. PubMed ID: 18175353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease.
    Hausdorff JM; Cudkowicz ME; Firtion R; Wei JY; Goldberger AL
    Mov Disord; 1998 May; 13(3):428-37. PubMed ID: 9613733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
    Delval A; Krystkowiak P; Blatt JL; Labyt E; Dujardin K; Destée A; Derambure P; Defebvre L
    J Neurol; 2006 Jan; 253(1):73-80. PubMed ID: 16096818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biomechanical study of gait initiation in Huntington's disease.
    Delval A; Krystkowiak P; Blatt JL; Labyt E; Bourriez JL; Dujardin K; Destée A; Derambure P; Defebvre L
    Gait Posture; 2007 Feb; 25(2):279-88. PubMed ID: 16820294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of spatiotemporal gait outcome measures in Huntington's disease.
    Rao AK; Quinn L; Marder KS
    Mov Disord; 2005 Aug; 20(8):1033-7. PubMed ID: 15838854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
    Pallier PN; Drew CJ; Morton AJ
    Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of the contingent negative variation in Huntington's disease: correlations with clinical features.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    J Neurol Sci; 2007 Mar; 254(1-2):84-9. PubMed ID: 17300807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease: modeling the gait disorder and proposing novel treatments.
    Banaie M; Sarbaz Y; Gharibzadeh S; Towhidkhah F
    J Theor Biol; 2008 Sep; 254(2):361-7. PubMed ID: 18621402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers?
    Delval A; Bleuse S; Simonin C; Delliaux M; Rolland B; Destee A; Defebvre L; Krystkowiak P; Dujardin K
    Gait Posture; 2011 Jun; 34(2):202-7. PubMed ID: 21616667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dual-task cognitive interference on gait and turning in Huntington's disease.
    Purcell NL; Goldman JG; Ouyang B; Liu Y; Bernard B; O'Keefe JA
    PLoS One; 2020; 15(1):e0226827. PubMed ID: 31910203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
    Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease.
    Johnson KA; Cunnington R; Bradshaw JL; Chiu E; Iansek R
    Mov Disord; 2002 Sep; 17(5):998-1003. PubMed ID: 12360549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculomotor deficits indicate the progression of Huntington's disease.
    Hicks SL; Robert MP; Golding CV; Tabrizi SJ; Kennard C
    Prog Brain Res; 2008; 171():555-8. PubMed ID: 18718352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gait dysfunction in Huntington's disease: parkinsonism and a disorder of timing. Implications for movement rehabilitation.
    Churchyard AJ; Morris ME; Georgiou N; Chiu E; Cooper R; Iansek R
    Adv Neurol; 2001; 87():375-85. PubMed ID: 11347241
    [No Abstract]   [Full Text] [Related]  

  • 19. Spatiotemporal gait characteristics of Huntington's disease during dual-task walking.
    Radovanović S; Vodopić S; Stanković I; Dragašević-Mišković N; Kostić V
    Int J Neurosci; 2020 Feb; 130(2):136-143. PubMed ID: 31516046
    [No Abstract]   [Full Text] [Related]  

  • 20. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.